BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3853963)

  • 1. In vitro activity of fosfomycin, alone and in combination, against methicillin-resistant Staphylococcus aureus.
    Alvarez S; Jones M; Berk SL
    Antimicrob Agents Chemother; 1985 Nov; 28(5):689-90. PubMed ID: 3853963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
    Graninger W; Leitha T; Breyer S; Francesconi M; Lenz K; Georgopoulos A
    Drugs Exp Clin Res; 1985; 11(1):23-7. PubMed ID: 3869801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Graninger W; Leitha T; Havel M; Georgopoulos A
    Infection; 1984; 12(4):293-5. PubMed ID: 6092279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo study of fosfomycin in methicillin-resistant Staphylococcus aureus septicaemia.
    Lau WY; Teoh-Chan CH; Fan ST; Lau KF
    J Hyg (Lond); 1986 Jun; 96(3):419-23. PubMed ID: 3637200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gentamicin- and methicillin-resistant, clinical isolates of Staphylococcus aureus: comparative in vitro and in vivo efficacy of alternative antimicrobial drugs.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1984; 30(2):102-12. PubMed ID: 6559664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antibiotic combinations on methicillin-resistant Staphylococcus aureus in vitro.
    Chang SC; Hsieh WC; Luh KT; Ho SW
    Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):488-92. PubMed ID: 2794948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus.
    Utsui Y; Ohya S; Magaribuchi T; Tajima M; Yokota T
    Antimicrob Agents Chemother; 1986 Dec; 30(6):917-22. PubMed ID: 3468883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
    Fosse T; David MF; Duluc F; Darmusey D; Tamalet C; Toga B
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.
    Guenthner SH; Wenzel RP
    Antimicrob Agents Chemother; 1984 Aug; 26(2):268-9. PubMed ID: 6237606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibacterial activities and electron microscopic studies of imipenem in combination with fosfomycin against methicillin and fosfomycin resistant strains of Staphylococcus aureus].
    Saionji K; Shitara S; Kobayashi I
    Jpn J Antibiot; 1990 Mar; 43(3):379-87. PubMed ID: 2374289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence, frequency and resistance characteristics of methicillin-oxacillin resistant Staphylococcus aureus strains in Germany].
    Voss A; Machka K; Lenz W; Milatovic D
    Dtsch Med Wochenschr; 1992 Dec; 117(50):1907-12. PubMed ID: 1459021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and -susceptible S. aureus.
    Goldstein EJC; Citron DM; Warren YA; Tyrrell KL; Rybak MJ
    J Med Microbiol; 2008 Apr; 57(Pt 4):452-456. PubMed ID: 18349364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergism between cefotaxime and fosfomycin in the therapy of methicillin and gentamicin resistant Staphylococcus aureus infection in rabbits.
    Chavanet P; Muggeo E; Waldner A; Dijoux S; Caillot D; Portier H
    Eur J Clin Microbiol Infect Dis; 1990 Apr; 9(4):271-5. PubMed ID: 2351143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Pistella E; Falcone M; Baiocchi P; Pompeo ME; Pierciaccante A; Penni A; Venditti M
    Infez Med; 2005 Jun; 13(2):97-102. PubMed ID: 16220029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Elwell LP; Wilson HR; Knick VB; Keith BR
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1092-4. PubMed ID: 3488022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus.
    Smith SM; Eng RH
    Antimicrob Agents Chemother; 1985 May; 27(5):688-91. PubMed ID: 3160301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin.
    Nakazawa H; Kikuchi Y; Honda T; Isago T; Nozaki M
    J Infect Chemother; 2003 Dec; 9(4):304-9. PubMed ID: 14691650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activities of antibiotics against methicillin-resistant Staphylococcus aureus with particular reference to synergetic effect between ticarcillin and fosfomycin on penicillinase non-producing methicillin-resistant S. aureus].
    Morikawa Y; Yoshioka Y; Toshima M
    Jpn J Antibiot; 1993 Jun; 46(6):421-7. PubMed ID: 8360977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains.
    Watanakunakorn C; Tisone JC
    Antimicrob Agents Chemother; 1982 Nov; 22(5):903-5. PubMed ID: 6924825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methicillin-oxacillin resistant strains of Staphylococcus aureus (MORSA) in infected burn wounds.
    Polaczek-Kornecka B; Dziadur-Goldsztaj Z; Turowski G
    Mater Med Pol; 1991; 23(4):304-5. PubMed ID: 1842238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.